Topics

Distributed Bio, Boehringer Ingelheim announce SuperHuman Platform Transfer

15:50 EST 11 Dec 2017 | CentreWatch

Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce an agreement with Boehringer Ingelheim to license the Distributed Bio SuperHuman Platform for accelerating biotherapeutics discovery across therapeutic areas. “The SuperHuman Platform represents the culmination of a decade of our research in computational library design,” says Jacob […]

The post Distributed Bio, Boehringer Ingelheim announce SuperHuman Platform Transfer appeared first on CenterWatch News Online.

Original Article: Distributed Bio, Boehringer Ingelheim announce SuperHuman Platform Transfer

NEXT ARTICLE

More From BioPortfolio on "Distributed Bio, Boehringer Ingelheim announce SuperHuman Platform Transfer"

Quick Search

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...